Acadia Pharmaceuticals reported $116.57M in Current Liabilities for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US USD 116.57M 1.11M
ALKERMES ALKS:US USD 469.56M 31.04M
Alnylam Pharmaceuticals ALNY:US USD 772.79M 115.11M
Aptinyx Inc APTX:US USD 2.69M 2.99M
Biogen BIIB:US USD 3.93B 1.09B
Biomarin Pharmaceutical BMRN:US USD 521.02M 56.29M
Bristol Myers Squibb BMY:US USD 18.93B 1.98B
Cara Therapeutics CARA:US USD 28.19M 7.02M
Corcept Therapeutics CORT:US USD 53.07M 4.01M
Cytokinetics CYTK:US USD 76.5M 9.65M
Eisai 4523:JP JPY 266.54B 35.36B
Eli Lilly And LLY:US USD 15.65B 32.2M
Intercept Pharmaceuticals ICPT:US USD 221.58M 70.16M
Intra Cellular Therapies ITCI:US USD 77.41M 6.78M
Marinus Pharmaceuticals MRNS:US USD 21.05M 2.06M
Moderna Inc MRNA:US USD 6.81B 5M
Neurocrine Biosciences NBIX:US USD 485.1M 199.4M
Pfizer PFE:US USD 44.31B 3.1B
Prothena PRTA:US USD 50.6M 10.49M
Ptc Therapeutics PTCT:US USD 420.08M 147.29M
Sarepta Therapeutics SRPT:US USD 602.92M 57.35M
Seattle Genetics SGEN:US USD 726M 117.48M
Ultragenyx Pharmaceutical RARE:US USD 227.36M 6.72M
Vanda Pharmaceuticals VNDA:US USD 92.62M 4.22M
Vertex Pharmaceuticals VRTX:US USD 2.61B 53.1M
YTE INCY:US USD 1.01B 79.92M